In evaluation of newly diagnosed hypertension, which test is indicated for all patients?

Enhance your Step 2 prep with AMBOSS 200 HY Concepts. Dive into flashcards and MCQs, each with detailed explanations. Ace your exam with confidence!

Multiple Choice

In evaluation of newly diagnosed hypertension, which test is indicated for all patients?

Explanation:
Baseline assessment of new hypertension focuses on uncovering early heart involvement and overall cardiovascular risk. An electrocardiogram is the test you’d obtain for every patient because it can detect left ventricular hypertrophy, prior silent myocardial infarction, and rhythm disturbances. These findings help gauge prognosis and may influence how aggressively you treat the blood pressure and whether further cardiac testing is needed. Other tests aren’t required in every case. A lipid panel is valuable for overall risk stratification and guiding lipid-lowering therapy, but it isn’t a direct diagnostic test for hypertension. Echocardiography and MRI are reserved for patients with signs or symptoms of cardiac disease or suspected structural problems, since routine imaging in all hypertensive patients rarely changes immediate management.

Baseline assessment of new hypertension focuses on uncovering early heart involvement and overall cardiovascular risk. An electrocardiogram is the test you’d obtain for every patient because it can detect left ventricular hypertrophy, prior silent myocardial infarction, and rhythm disturbances. These findings help gauge prognosis and may influence how aggressively you treat the blood pressure and whether further cardiac testing is needed.

Other tests aren’t required in every case. A lipid panel is valuable for overall risk stratification and guiding lipid-lowering therapy, but it isn’t a direct diagnostic test for hypertension. Echocardiography and MRI are reserved for patients with signs or symptoms of cardiac disease or suspected structural problems, since routine imaging in all hypertensive patients rarely changes immediate management.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy